Moderna's Post-Pandemic Crisis: From Vaccine Success to Corporate Challenges
Exclusive: The inside story of why Moderna now faces a crisis unlike any in its 15-year-history.
Read the full articleYou might also wanna read
Moderna CEO discusses bioterrorism fears and Europe's pandemic preparedness in post-COVID landscape
Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterr
l.euronews.com·1mo ago10-year Moderna deal underlines UK potential for global life science leadership
The partnership with Moderna will see a new Innovation and Technology Centre in the UK, which will create more than 150 highly skilled jobs
Short Squeeze Alert—Moderna Stock Surges on New Strategy
Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-ye
Moderna's combined flu and COVID-19 mRNA vaccine shows durable immune response in mid-stage trial
A single dose of mRNA-1073 elicited durable immune responses through 6 months against all vaccine-matched influenza and SARS-CoV-2 strains.
cidrap.umn.edu·1mo ago
Watch: Canadian Woman Paralyzed After Moderna COVID Shot Says Government ‘Not Doing Their Job’
Kayla Pollock, who said she woke up paralyzed from the neck down after a Moderna COVID-19 vaccine, told The Defender she is still waiting fo
Why we need a blueprint for a post-vaccine world, helping domestic abuse victims during COVID-19, the pandemic's historic economic effects, and more.
We discuss how to ensure that a vaccine—once ready—is accessible and affordable; what more can be done to address the rise in domestic viole
Comments
Sign in to join the conversation.
No comments yet. Be the first.